Oslo - Delayed Quote NOK

Photocure ASA (PHO.OL)

55.40 +1.00 (+1.84%)
At close: April 26 at 4:25 PM GMT+2
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
462,301.00
393,132.00
360,540.00
256,482.00
Cost of Revenue
25,865.00
22,697.00
24,050.00
18,511.00
Gross Profit
436,435.00
370,434.00
336,490.00
237,971.00
Operating Expense
454,201.00
419,437.00
342,316.00
261,175.00
Operating Income
-17,766.00
-49,003.00
-5,826.00
-23,204.00
Net Non Operating Interest Income Expense
-19,149.00
-23,667.00
-21,916.00
-2,137.00
Pretax Income
-35,379.00
-71,134.00
-31,656.00
-33,226.00
Tax Provision
-1,687.00
723.00
-759.00
-10,823.00
Net Income Common Stockholders
-33,692.00
-71,857.00
-30,897.00
-22,403.00
Diluted NI Available to Com Stockholders
-33,692.00
-71,857.00
-30,897.00
-22,403.00
Basic EPS
-1.24
-2.66
-1.15
-0.91
Diluted EPS
-1.24
-2.66
-1.15
-0.91
Basic Average Shares
27,088.02
27,034.98
26,843.34
24,621.49
Diluted Average Shares
27,126.33
27,148.74
27,107.89
24,795.42
Total Operating Income as Reported
42,737.00
-49,003.00
-5,826.00
-36,058.00
Total Expenses
480,066.00
442,134.00
366,366.00
279,686.00
Net Income from Continuing & Discontinued Operation
-33,692.00
-71,857.00
-30,897.00
-22,403.00
Normalized Income
-32,970.14
-71,265.76
-16,001.70
-14,574.91
Interest Income
13,252.00
2,336.00
1,810.00
5,657.00
Interest Expense
32,202.00
25,804.00
23,826.00
7,028.00
Net Interest Income
-19,149.00
-23,667.00
-21,916.00
-2,137.00
EBIT
-3,177.00
-45,330.00
-7,830.00
-26,198.00
EBITDA
23,298.00
-20,952.00
16,297.00
-6,906.00
Reconciled Cost of Revenue
25,865.00
22,697.00
24,050.00
18,511.00
Reconciled Depreciation
26,475.00
24,378.00
24,127.00
19,292.00
Net Income from Continuing Operation Net Minority Interest
-33,692.00
-71,857.00
-30,897.00
-22,403.00
Total Unusual Items Excluding Goodwill
-758.00
-758.00
-17,220.00
-12,854.00
Total Unusual Items
-758.00
-758.00
-17,220.00
-12,854.00
Normalized EBITDA
24,056.00
-20,194.00
33,517.00
5,948.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-36.14
-166.76
-2,324.70
-5,025.91
12/31/2020 - 5/30/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NEWBRY.ST Newbury Pharmaceuticals AB (publ)
3.4100
+2.71%
 
0512.HK Grand Pharmaceutical Group Limited
4.320
+1.41%
 
HLUN-A.CO H. Lundbeck A/S
28.15
+0.72%
 
NXS.AX Next Science Limited
0.3400
+7.94%
 
BIOG-B.ST BioGaia AB (publ)
115.20
+1.23%
 
HLUN-B.CO H. Lundbeck A/S
32.92
+1.11%
 
HROW Harrow, Inc.
10.53
+5.30%
 
CPH.TO Cipher Pharmaceuticals Inc.
8.50
0.00%
 
SIGA SIGA Technologies, Inc.
8.79
+1.74%
 
ELAN Elanco Animal Health Incorporated
13.26
+1.69%